Back to search
FDAFDA · Food and drugs·Recall number D-1155-2022

Clonazepam Orally Disintegrating Tablets, USP, 0.125mg, Rx Only, 60 Tablets, Mfd. by: Sun Pharmaceutical Industries Ltd. Mumbai, India, Dist. by: Sun Pharmaceutical Industries In., Cranbury, NJ 08512, NDC 57664-783-68, packaged in bottles.

Published June 29, 2022 · Recall initiated: June 3, 2022

Summary

FDA records drug Class II recall D-1155-2022, published June 29, 2022 and initiated June 3, 2022. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 4608 bottles; Lot: Lot #: MHC1430A, Exp. Date 09/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specification; oversized tablet found in a bottle

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
nationwide within the United States
Lot
Lot #: MHC1430A, Exp. Date 09/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clonazepam Orally Disintegrating Tablets, USP, 0.125mg, Rx Only, 60 Tablets, Mfd. by: Sun Pharmaceutical Industries Ltd. Mumbai, India, Dist. by: Sun Pharmaceutical Industries In., Cranbury, NJ 08512, NDC 57664-783-68, packaged in bottles. recalled?

Yes. FDA published recall D-1155-2022 on June 29, 2022. Reported hazard: Failed Tablet/Capsule Specification; oversized tablet found in a bottle

What should I do if I have this product?

Voluntary: Firm initiated · Letter